During the 19th Annual Meeting ov the Japanese Vaccine Society Michiho OHARA announced having developed a recombinant vaccinia virus vaccine (LC16m8rVV-Flu HA) effective against H5N1 influenza.

Nikkei Biotech news release, November 18, 2015